Feature | August 30, 2013

Protocols Developed for Diagnosing Pericardial Disease Using Multi-modality Imaging

Diagnosing Pericardial Disease Using Multi-modality Imaging Protocols

August 30, 2013 — To counter the significant levels of morbidity and mortality associated with pericardial disease (disease of the sac around the heart), experts from the American Society of Echocardiography (ASE), the Society for Cardiovascular Magnetic Resonance (SCMR), and the Society of Cardiovascular Computed Tomography (SCCT) came together to review evidence and provide future guidance to clinicians. For the first time, an expert consensus statement on the appropriate use of multimodality imaging in the diagnosis and management of pericardial diseases will be published in the September issue of the Journal of the American Society of Echocardiography (JASE). The writing group was chaired by Allan L. Klein, M.D., FASE, director of Cardiovascular Imaging Research and the Pericardial Center and an echocardiographer from the esteemed Cleveland Clinic in Cleveland, Ohio.

When asked about the need for this guideline document, Klein remarked, “Pericardial disease is very common worldwide and can present in a wide range of symptoms and etiologies, making diagnosis and management clinically difficult. This document will allow clinicians in a variety of settings including primary care, emergency room and subspecialty settings, such as rheumatology, oncology and cardiology, to weigh the strengths and weaknesses of a particular imaging modality to evaluate and manage patients with suspected pericardial disease. The incremental information provided by these advanced imaging modalities may alter clinical decision making and potentially even improve outcomes.”

All patients with suspected pericardial disease, including acute, recurrent, and constrictive pericarditis as well as pericardial effusion, should have an echocardiogram as the initial diagnostic test followed by cardiac magnetic resonance imaging (MR) and/or cardiac CT, if necessary (especially in patients with poor prognostic signs such as failure to respond to anti-inflammatories), according to the guidelines. Echo emerges as the front-line imaging test used to detect most pericardial syndromes because of its ease of use, wide availability, bedside readiness, cost-effectiveness, and its comprehensive assessment of both anatomy and physiology. However, the guidelines also include a number of tables, images and other resources to guide clinicians through a stepwise approach to appropriately utilizing imaging in the diagnosis and management of various pericardial diseases. For example, CT should be used if there is calcification of the pericardium as in constrictive pericarditis.

The guidelines also emphasize the important role of inflammation in the pericardial sac often detected by cardiac MR, which then can be targeted with intense anti-inflammatory therapy. There is also an accompanying appendix, aimed at sonographers and imaging technologists, which reviews the technical approach in performing detailed “Diastology” echocardiograms, as well as the sequences and settings for cardiac MR and CT exams. 

For more information: www.onlinejase.com

 

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI)| September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT)| September 15, 2017
Hitachi Healthcare Americas Inc. announced it has attained U.S. Food and Drug Administration (FDA) 510(k) clearance to...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT)| September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Technology | Radiation Dose Management| September 07, 2017
September 7, 2017 — Sapheneia and Scannerside received U.S.
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
GE’s blood speckle imaging (BSI) software shows the flow of blood cells’ trajectories. It is a form of blood vector flow imaging.

GE’s blood speckle imaging (BSI) software offers the ability to view a graphical representation of the blood cells’ trajectories.

News | Cardiovascular Ultrasound| September 01, 2017
Cardiologists are constantly on the lookout for new methods to examine the heart using new imaging technology advance
GE Healthcxare Signa Pioneer MAGIC six contrasts in one scan software by SyntheticMR.

The MRI software enables several different contrasts to be obtained from one scan, shortening scan times.

Feature | Magnetic Resonance Imaging (MRI)| August 31, 2017
August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI.
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init